Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-05-28 00:00:00 ET · period of report 2025-05-27 · accession 0000950170-25-078552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-05-28 | 2025-05-27+ | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $104.07 | -40.7K | 5,783 | -88% | -$4.23M |
| DMT | 2025-05-28 | 2025-05-27+ | AXSM | Jacobson Mark L. | COO | M - OptEx | $6.47 | +40.7K | 26.5K | New | +$263.2K |
| DMT | 2025-05-28 | 2025-05-27+ | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -40.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-28 | S | D | 20,000 | $103.45 | 5,783 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $102.67 and $104.22. |
| 2 | Common | Common Stock | 2025-05-28 | M | A | 20,000 | $6.47 | 25,783 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-27 | S | D | 20,673 | $104.66 | 5,783 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $103.96 and $106.44. |
| 4 | Common | Common Stock | 2025-05-27 | M | A | 20,673 | $6.47 | 26,456 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-05-27 | M | D | 20,673 | $0.00 | 0 | D | $6.47 · 2016-09-15 to 2025-09-15 | 20,673 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-05-28 | M | D | 20,000 | $0.00 | 0 | D | $6.47 · 2016-09-15 to 2025-09-15 | 20,000 Common Stock |